Akzo's gepirone ER not approvable

Akzo (Euronext:AKZ; AKZOY) subsidiary Organon (Oss, the Netherlands) received an FDA not approvable letter for gepirone ER, a serotonin (5-HT1A) receptor agonist (formerly Ariza) to treat major depres...